Diet-Related Lipidomic Signatures and Changed Type 2 Diabetes Risk in a Randomized Controlled Feeding Study With Mediterranean Diet and Traditional Chinese or Transitional Diets.

"Duality of Interest. No potential conflicts of interest relevant to this article were reported."

"Funding. The study was supported by the Strategic Priority CAS Project (XDB38010300 and XDB38020000), Shanghai Municipal Science and Technology Major Project (2017SHZDZX01), Chinese Academy of Sciences (ZDBS-SSW-DQC-02 and KJZD-EW-G20-02), and the National Natural Science Foundation of China (81970684 and 81700700)."

"The DPMH is a parallel-arm randomized controlled trial comparing the effects of a Mediterranean diet, traditional Jiangnan diet, and control diet on body weight and glucose homeostasis (ClinicalTrials.gov: NCT03856762), as reported previously (). In brief, the DPMH included 253 participants age 25–60 years, with BMI ≥24 kg/m2 and fasting glucose ≥5.6 mmol/L, from SAIC Volkswagen Automotive Company in Shanghai, China in 2019. Participants were randomly assigned to a Mediterranean diet (n = 84), traditional Jiangnan diet (n = 85), or control diet (n = 84) for 6 months. A total of 231 participants were included in the present analysis after excluding those who left the trial after less than 3 months."